Be an Advocate

You don’t need  special title or role to speak up for the kidney cancer community. In fact, when it comes to advocacy, the heavy lifting is done with small, consistent efforts by people just like you.

Whether you’re a patient, caregiver, family or friend, or a researcher or doctor — we need you. If you want to increase research funding and accelerate cures for kidney cancer, you belong here.

A Place for Everyone

Advocating for kidney cancer research funding doesn’t have to take up a lot of your time. There are simple steps you can take to keep in touch with our community and pitch in with what you can, when you can. Check out the options below!

KEEP IN TOUCH WITH US ONLINE

Spread awareness and stay in the loop with advocacy events by joining our online communities. We’re on social media and on Smart Patients, and we’d love for you to join us! When you share our posts, add your comments, join our online events, and watch our videos, you are amplifying our efforts and increasing our reach. It’s a simple way to make a difference!

JOIN US ON ADVOCACY DAYS

No experience necessary! Advocacy Days are generally two-day events, where you meet with your Congressional reps in person or via Zoom. We train you, so you know what to say to convince Congress to fund kidney cancer research. Virtual advocacy days especially do not take up a lot of time and make an enormous impact on research funding. Your story matters!

WRITE A LETTER TO CONGRESS

A simple but personal letter can be a powerful tool to encourage your representatives to fund kidney cancer research. We work each year to ask for increased funding for the National Institutes of Health and the CDMRP’s Kidney Cancer Research Program. If you can’t join us for Advocacy Day events, consider adding your voice with a letter or email.

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

#ESMO21 : QoL is one of the main pillars that should always be kept in mind in the treatment of patients with mRCC!! @myESMO @OncoAlert @AlbigesL
@kidneycan @KidneyCancer @urotoday

#ESMO21 @myESMO GU proffered session Lively question/answer session & discussion led by @AlbigesL , @brian_rini 👉 maintaining patients QOL , a fundamental goal in oncology, + intermittent ...TKI/dose modification may be used in selected patients with #kidneycancer @OncoAlert

Please take a moment to answer this poll from @SoaresAndrey - @kidneycan @KidneyCancer @KCA_Journal https://t.co/NFE46gAslk

After STAR trial results would you consider to recommend treatment interval strategy for patients receiving TKI in 2L after IO based therapy in 1L? Please RT @montypal @drenriquegrande @tompowles1 @cdanicas @brian_rini @TiansterZhang @ERPlimackMD @motzermd @DrChoueiri @AlbigesL

#ESMO21 @myESMO Keynote-564 trial 👉 adjuvant pembrolizumab significantly delay #kidneycancer disease recurrence without compromising patient reported quality of like + physical function ...@DrChoueiri @OncoAlert @kidneycan @tompowles1

Inspiring mood! Resilience. Flipping the switch. Tackling the next next.
🧡💚

I’m resilient. Spent the morning in meltdown, then flipped the switch.

I had a great time at PT, kicked ass.

Looked at my scans again. It could be worse.

Back in the saddle at work too and ready to figure out the next next for my kidney cancer.

Being presented by Dr. Andy Hahn at #ESMO21, a recent study suggests cytoreductive nephrectomy should be considered in patients with certain types of renal cell carcinoma treated with immune ...checkpoint inhibitors: https://t.co/PEMVPxRHzr. #EndCancer https://t.co/aogP46FtTb

Looking forward to #ESMO21 @myESMO. Check out our poster on cytoreductive nephrectomy in met sarcomatoid and/or rhabdoid RCC who receive ICI. Mentored by @PavlosMsaouel @MDAndersonNews

Can’t think of a more deserving individual! Bringing people together across the globe with the mission to improve cancer outcomes for all patients. @DrChoueiri congrats! https://t.co/XlRxemLcRQ

Dear friends

An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards

We are SO PROUD & congratulate him on this well deserved award!

From those of us who have known you as a GIANT in this field for years already to those just learning today with the announcement of this award, may I say this is SO well deserved. May you never lose... your drive and passion for improving the lives of your patients, @DrChoueiri! https://t.co/kmpltahXl9

Dear friends

An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards

We are SO PROUD & congratulate him on this well deserved award!

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter...

read more
District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for...

read more

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...